Prospective observational study of cancer-associated thrombosis in patients with newly diagnosed pancreatic cancer

Prospective observational study of cancer-associated thrombosis in patients with newly diagnosed pancreatic cancer - Prospective observational study of cancer-associated thrombosis in patients with newly diagnosed pancreatic cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044564

Enrollment

Registered

2021-06-21

Start date

2021-06-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.informed consent in writing given freely. 2.20 years old or older at written informed consent. 3.patients with newly diagnosed pancreatic cancer. 4.patients with a definitive diagnosis of pancreatic cancer pathologically

Exclusion criteria

Exclusion criteria: 1.patients with serious complications in other organs. 2.patients with postoperative recurrence of pancreatic cancer. 3.patients who are inappropriate as a subject of the study judged by the treating physicians.

Design outcomes

Primary

Measure	Time frame
the incidence of cancer-associated thrombosis during the observation period	—

Secondary

Measure	Time frame
1. the incidence of intracardiac thrombus on transesophageal echocardiography at the time of the endoscopic ultrasound-guided fine needle aspiration 2.the risk factor of cancer-associated thrombosis 3.thrombosis improvement rate and complication rate by anticoagulant therapy for cancer-associated thrombosis 4.over all survival 5.progression free survival	—

Countries

Japan

Contacts

Public ContactKentaro Oki

Japanese Red Cross Okayama Hospital Gastroenterology

p023eb@gmail.com086-222-8811

Outcome results